Business Description
TelyRx Holdings Inc
NAICS : 456110
SIC : 6031
ISIN : CA87974Y1043
Share Class Description:
TSX:TELY: Ordinary Shares (Sub Voting)Compare
Compare
Traded in other countries / regions
TELY.Canada IPO Date
2026-04-07Description
TelyRx Holdings Inc is a vertically integrated technology enabled healthcare and pharmacy services provider, operating a digital pharmacy platform that connects patients with independent, state-licensed providers. The TelyRx platform provides the Providers with access to a clinically focused electronic medical records system and the ability for them to electronically prescribe. TelyRx enables patient access to a risk-curated formulary of over 450 noncontrolled, and non-compounded prescription medications selected by the Providers to address a broad cross-section of everyday chronic and acute ailments.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 2.11 | |||||
Equity-to-Asset | 0.41 | |||||
Debt-to-Equity | 0.91 | |||||
Debt-to-EBITDA | -1.73 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 3.39 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 45.38 | |||||
9-Day RSI | 47.31 | |||||
14-Day RSI | 48.49 | |||||
3-1 Month Momentum % | -21 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.9 | |||||
Quick Ratio | 3.74 | |||||
Cash Ratio | 3.52 | |||||
Days Inventory | 21.92 | |||||
Days Sales Outstanding | 4.61 | |||||
Days Payable | 48.46 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -1.66 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 55.26 | |||||
Operating Margin % | -14.41 | |||||
Net Margin % | -19.17 | |||||
EBITDA Margin % | -15.98 | |||||
FCF Margin % | -4.84 | |||||
OCF Margin % | -3.78 | |||||
ROE % | -32851.35 | |||||
ROA % | -50.34 | |||||
ROIC % | -87.11 | |||||
ROC (Joel Greenblatt) % | -249.86 | |||||
ROCE % | -98.34 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 1.02 | |||||
PB Ratio | 3.59 | |||||
Price-to-Tangible-Book | 3.88 | |||||
EV-to-EBIT | -9.5 | |||||
EV-to-EBITDA | -10.56 | |||||
EV-to-Revenue | 1.68 | |||||
EV-to-Forward-Revenue | 0.6 | |||||
EV-to-FCF | -38.85 | |||||
| Price-to-Net-Current-Asset-Value | 5.2 | |||||
| Price-to-Net-Cash | 7.43 | |||||
Earnings Yield (Greenblatt) % | -10.51 | |||||
FCF Yield % | -2.42 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
TelyRx Holdings Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | 63.422 | ||
| EPS (TTM) (C$) | -0.492 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 48.49 | ||
| 14-Day ATR (C$) | 0.235233 | ||
| 20-Day SMA (C$) | 2.64175 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (C$) | 2 - 4.25 | ||
| Shares Outstanding (Mil) | 26.58 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
TelyRx Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
TelyRx Holdings Inc Stock Events
| Event | Date | Price (C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
TelyRx Holdings Inc Frequently Asked Questions
What is TelyRx Holdings Inc(TSX:TELY)'s stock price today?
The current price of TSX:TELY is C$2.60. The 52 week high of TSX:TELY is C$4.25 and 52 week low is C$2.00.
When is next earnings date of TelyRx Holdings Inc(TSX:TELY)?
The next earnings date of TelyRx Holdings Inc(TSX:TELY) is .
Does TelyRx Holdings Inc(TSX:TELY) pay dividends? If so, how much?
TelyRx Holdings Inc(TSX:TELY) does not pay dividend.
Press Release
Articles on TelyRx Holdings Inc
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers